Abbott Laboratories (NYSE:ABT) Q4 2024 Earnings Call Transcript January 22, 2025Abbott Laboratories reports earnings inline with expectations.
Keep Reading →
January 23 - News, Transcripts
The earnings season is in full flow as we kick off the week with earnings from big names like Netflix and United Airlines.
Keep Reading →
January 21 - News, Stock Analysis
Jim Cramer, host of Mad Money, recently emphasized the importance of long-term investing, urging investors to focus on the growth prospects of certain pharmaceutical stocks while...
Keep Reading →
January 18 - Hedge Funds, News
In one of his latest appearances on CNBC's Squawk on the Street, Jim Cramer started the morning by commenting on the latest Producer Price Index (PPI) release.
Keep Reading →
January 15 - News
In 2024, dividend stocks fell short of investor expectations, largely due to the continuing AI boom and a heightened interest in technology stocks.
Keep Reading →
January 6 - Dividend Stocks, Hedge Funds, News
Healthcare has been one of Jim Cramer's favorite topics lately.
Keep Reading →
December 31 - News
Heather Brilliant’s Diamond Hill Capital is a Columbus, Ohio-based investment management firm founded in 1997 by Ric Dillon, who managed the company until 2019. Mr.
Keep Reading →
December 26 - Hedge Funds, News
Investors often focus on stock price movements, anticipating gains, but may underestimate the value of dividends as a key component of returns.
Keep Reading →
December 9 - Dividend Stocks, Hedge Funds, News
This year, dividend stocks have underperformed compared to the broader market, largely because tech stocks have captured most of the attention.
Keep Reading →
November 16 - Dividend Stocks, Hedge Funds, News
The stock market at the tail end of 2024 is an evolution of the patterns we've observed since the start of the coronavirus pandemic.
Keep Reading →
November 5 - Market Movers, News
Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of ...
Keep Reading →
November 4 - Hedge Funds, Industries, News
Abbott Laboratories (ABT) stock has had negative returns for the last 3 years. But don't get fooled by that when analyzing the stock's performance.
Keep Reading →
October 23 - News, Stock Analysis
Operator: Good day, and thank you for standing by. Welcome to Abbott's Third Quarter 2024 Earnings Conference Call.
Keep Reading →
October 17 - News, Transcripts
The medical and healthcare industry is one of the largest globally, with a steady demand for products and services due to the biological nature of humans.
Keep Reading →
October 15 - News
As earnings season kicks off, Jim Cramer of Mad Money offered insights on what investors should watch in the coming week on Wall Street.
Keep Reading →
October 15 - Hedge Funds, News
The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are expected to see GDP boosts of 26% and 14.5%, respectively...
Keep Reading →
October 5 - Hedge Funds, Industries, News, Tech
The global kidney treatment and dialysis market is experiencing typical growth levels.
Keep Reading →
September 28 - Hedge Funds, News, Stock Analysis
Investing in healthcare equities is typically seen as protective during difficult economic times.
Keep Reading →
September 27 - News, Stock Analysis
In 2022, the global oncology market was valued at approximately $203.42 billion and is expected to reach over $470.61 billion by 2032, growing at a compound annual growth rate...
Keep Reading →
August 31 - Hedge Funds, Industries, News
On a recent episode of Mad Money, Jim Cramer notes that after a significant rally in the past two weeks, the market took a hit ahead of the Federal Reserve's upcoming meeting ...
Keep Reading →
August 25 - Hedge Funds, News
The appeal of dividend growth growth stocks is unmatched.
Keep Reading →
August 19 - Dividend Stocks, Hedge Funds, News
Shifts in investment trends have revealed new insights for investors in recent years.
Keep Reading →
August 12 - Dividend Stocks, Hedge Funds, News
In the dynamic landscape of healthcare, the importance of organ transplantation cannot be overstated.
Keep Reading →
August 6 - Hedge Funds, Industries, News
Diamond Hill Capital, an investment management company, released its “Select Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
July 30 - Hedge Fund Investor Letters, News
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” second quarter 2024 investor letter.
Keep Reading →
July 24 - Hedge Fund Investor Letters, News
Operator: Good morning and thank you for standing by. Welcome to Abbott’s second quarter 2024 earnings conference call.
Keep Reading →
July 20 - News, Transcripts
The AI sector maintained its momentum unabated in the second quarter of 2024, with tech stocks continuing to lead the charge.
Keep Reading →
July 4 - Dividend Stocks, Hedge Funds, News
Investors often closely track the fluctuations of the stock market, eagerly expecting price increases.
Keep Reading →
June 20 - Dividend Stocks, Hedge Funds, News
Billionaire Paul Tudor Jones recently made headlines after he participated in the Robin Hood foundation's fundraising event dressed as Neo from the movie "The Matrix." The event...
Keep Reading →
June 9 - Hedge Funds, News
The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm.
Keep Reading →
June 6 - Dividend Stocks, Hedge Funds, News
This article presents an overview of Jim Cramer is Recommending These 5 Stocks. For a detailed overview of such stocks read our article, Jim Cramer is Recommending These...
Keep Reading →
May 22 - Hedge Funds, News
In this article, we discuss 11 best recession dividend stocks to buy.
Keep Reading →
May 6 - Dividend Stocks, Hedge Funds, News
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Keep Reading →
April 19 - Hedge Fund Investor Letters, News
Operator: Good morning, and thank you for standing by. Welcome to Abbott's First Quarter 2024 Earnings Conference Call.
Keep Reading →
April 18 - News, Transcripts
This article presents an overview of Jim Cramer is Recommending These 5 Stocks in April. For a detailed overview of such stocks, read our article, Jim Cramer is Recommending...
Keep Reading →
April 15 - Hedge Funds, News
This article presents an overview of Jim Cramer’s 5 Favorite Healthcare Stock Picks in 2024. For a detailed overview of such stocks, read our article, Jim Cramer’s 10 ...
Keep Reading →
April 13 - Hedge Funds, News
This article presents an overview of 5 Magnificent Dividend Growth Stocks to Buy and Hold Forever. For a detailed overview of such stocks, read our article, 11 Magnificent...
Keep Reading →
April 2 - Hedge Funds, News
In this article, we will discuss the 14 Best Medical Device Stocks To Buy Now.
Keep Reading →
March 26 - Hedge Funds, News
In this article, we will be taking a look at the 16 most undervalued large-cap stocks to buy according to analysts.
Keep Reading →
March 24 - News, Quantitative Investing
In this article, we will look at the 15 highest paying countries for biomedical engineers. We have also discussed the global bioengineering technology market.
Keep Reading →
March 22 - Lists, News
In this article, we discuss 10 undervalued dividend aristocrats to buy according to analysts.
Keep Reading →
March 19 - Dividend Stocks, Hedge Funds, News
In this article, we discuss 5 dividend kings to invest in for safe dividend growth.
Keep Reading →
March 12 - Dividend Stocks, Hedge Funds, News
In this article, we discuss 13 best performing dividend stocks to invest in.
Keep Reading →
February 27 - Dividend Stocks, Hedge Funds, News
Polen Capital, an investment management company, released its “Polen Global Growth Strategy” fourth-quarter 2023 investor letter.
Keep Reading →
February 26 - Hedge Fund Investor Letters, News
It's commonly said among investor circles that short selling is one of the most difficult strategies to make money in the stock market. The events of 2023 showed why.
Keep Reading →
February 21 - Hedge Funds, News
In this article, we will look into the 20 most sustainable companies in the US.
Keep Reading →
February 20 - Business, Industries, Lists, News
In this article, we will be taking a look at the 5 most valuable medical device companies in the US.
Keep Reading →
February 18 - News
In this article, we will take a look at the 30 most valuable drug companies in 2024.
Keep Reading →
February 10 - Business, Industries, Lists, News
Abbott Laboratories reports earnings inline with expectations. Reported EPS is $1.19 EPS, expectations were $1.19.
Keep Reading →
January 25 - News, Transcripts
In this article, we discuss the 12 healthcare stock options to add to your retirement portfolio.
Keep Reading →
January 20 - Hedge Funds, News